J7-70266
Silver-111-labelled theranostic radiopharmaceuticals for CCK2R-expressing tumours - THERA.SI, 1.3.2026-28.2.2029, Marko Štrok (O2)
Silver-111-labelled theranostic radiopharmaceuticals for CCK2R-expressing tumours - THERA.SI, 1.3.2026-28.2.2029, Marko Štrok (O2)